Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Brain, Body, Cognition - A continuation of Functional Neurology, Rehabilitation and Ergonomics
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Drugs During Pregnancy
Tell A Friend
Tell someone you know about this product.
Drugs During Pregnancy
Retail Price: $162.00
10% Online Discount
You Pay:

Authors: Bengt Klln (Tornblad Insitute, University of Lund, Lund, Sweden 
Book Description:
This book discusses the problems in studying the effect of maternal drug use during pregnancy and delivery outcome, including congenital malformations and other defects of the infants. For each main category of relevant drugs, information gathered from the literature and data obtained from the Swedish Medical Birth Register are used. This register is a rather unique source of information because during the time interval studies, nearly one million women have been interviewed in early pregnancy about the use of drugs during pregnancy and data from their deliveries and their infants have been collected. This book will contribute to the scientific literature because of much of the data have never been published as scientific articles and previously published data will be updated

Weve partnered with Copyright Clearance Center to make it easy for you to request permissions to reuse Nova content.
For more information, click here or click the "Get Permission" button below to link directly to this book on Copyright Clearance Center's website.

Table of Contents:

Abbreviations used

Chapter 1: A short history of the study of maternal drug use and delivery outcome.( pp .1-4)

Chapter 2: The practical consequences of drug effects on delivery outcome (pp. 5-8)

Chapter 3: Swedish health registers used and variables studied. (pp. 9-16)

Chapter 4: Advantages and disadvantages of the study material (pp. 17-20)

Chapter 5: Strategy of analysis (pp. 21-24)

Chapter 6: Data on women and infants recorded in the Medical Birth Register during 1996-2006 (pp. 25-32)

Chapter 7: Antacids (pp. 33-38)

Chapter 8: Drugs used for gastric ulcer and gastro-oesophageal reflux (pp.39-48)

Chapter 9: Drugs used for functional intestinal symptoms (pp.49-56)

Chapter 10: Antiemetic drugs (pp. 57-62)

Chapter 11: Bile acid preparations (pp.63-66)

Chapter 12: Laxatives.(pp.67-72)

Chapter 13: Drug Chapter s used as anti-diarrhoics, intestinal anti-infectives, or at inflammatory bowel disease (pp.73-82)

Chapter 14: Anti-obesity drugs (pp.83-88)

Chapter 15: Digestives, including enzymes (pp. 89-92)

Chapter 16: Drugs for diabetes (pp.93-100)

Chapter 17: Vitamins and minerals (pp.101-108)

Chapter 18: Anabolic steroids (pp.109-110)

Chapter 19: Anticoagulants (pp.111-120

Chapter 20: Haemostatics (pp.121-126)

Chapter 21: Vitamin B12 and folic acid (pp. 127-136)

Chapter 22: Drugs for cardiac diseases (pp.137-142)

Chapter 23: Antihypertensive drugs (pp.143-150)

Chapter 24: Diuretics (pp.151-156)

Chapter 25: Serum lipid reducing agents (pp.157-164)

Chapter 26: Dermatological drugs (pp.165-174)

Chapter 27: Gynaecological drugs (pp.175-180)

Chapter 28: Prolactin inhibitors and dopamine agonists (pp.181-186)

Chapter 29: Oral contraceptives (pp.187-192)

Chapter 30: Sex hormones other than oral contraceptives (pp.193-200)

Chapter 31: Ovulation stimulants (pp.201-208)

Chapter 32: Urologicals (pp.209-212)

Chapter 33: Hypophyseal hormones and hypothalamic hormones (except gonadotrophines) and analogues (pp.213-220)

Chapter 34: Corticosteroids used systemically (pp.221-228)

Chapter 35: Thyroid hormones and anti-thyroid drugs.pp.229-238

Chapter 36: Antibiotics used systemically (pp.239-250)

Chapter 37: Antimycotics used systemically (pp.251-256)

Chapter 38: Tuberculostatics (pp.257-260)

Chapter 39: Anti-virus drugs (pp.261-268)

Chapter 40: Immunoglobulins (pp.269-274)

Chapter 41: Vaccines (pp.275-282)

Chapter 42: Antineoplastic, immunomodulating and immunosuppressive drugs (pp.283-292)

Chapter 43: Non-steroid anti-inflammatory drugs (pp.293-300)

Chapter 44: Muscle-relaxing drugs (pp.301-308)

Chapter 45: Other drugs for musculo-skeletal diseases (pp.309-310)

Chapter 46: Analgesics (except drugs for migraine) (pp.311-318)

Chapter 47: Drugs for migraine (pp.319-326)

Chapter 48: Anticonvulsant drugs (pp.327-336)

Chapter 49: Drugs for parkinsonism (pp.337-340)

Chapter 50: Antipsychotic drugs (pp.341-350)

Chapter 51: Sedatives and hypnotics (pp.351-358)

Chapter 52: Antidepressive drugs (pp.359-368)

Chapter 53: Other drugs affecting he nervous system (pp. 369-374)

Chapter 54: Antimalarials (pp.375-382)

Chapter 55: Anthelmintics (pp.383-388)

Chapter 56: Drugs for ectoparasites (pp.389-390)

Chapter 57: Nasal decongestant preparations (pp.391-398)

Chapter 58: Antiasthmatic drugs (pp.399-408)

Chapter 59: Cough medicines (pp.409-414)

Chapter 60: Antihistamines (pp. 415-424)

Chapter 61: Ophthalmologicals (pp.425-432)

Chapter 62: Otologicals (pp.433-436)

Index (pp.437-450)

      Pregnancy and Infants: Medical, Psychological and Social Issues
   Binding: Hardcover
   Pub. Date: 2009
   Pages: pp.450
   ISBN: 978-1-60876-154-8
   Status: AV
Status Code Description
AN Announcing
FM Formatting
PP Page Proofs
FP Final Production
EP Editorial Production
PR At Prepress
AP At Press
AV Available
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2020

Drugs During Pregnancy